Charter Life Sciences (CLS) is an early stage life sciences venture capital investor. The firm typically leads and makes its initial investment in a company's first round of institutional financing. After investment, CLS provides continuing strategic and financial support through each phase of its portfolio company's development. The firm invests in early stage companies that are developing emerging products and technologies that address a significant unmet clinical need within a large and growing market segment. CLS will also consider later stage investments in cases where the portfolio company is undergoing a directional change or transition.
Venture Capital
320 LOGUE AVENUE
SUITE 135
MOUNTAIN VIEW, CA, 94043
United States
1 funds found in our dataset.
Built for investment teams that need to move faster.
Intelligently process data room financials, generate auditable analyses, and export IC-ready deliverables.